January 21, 2023
July 2022: Meducom supports development of information cards for patients
When patients are diagnosed with cancer, they may be overwhelmed with questions. What is going…
Read More
January 21, 2023
March 2022: Meducom supports important publication on reduced cardiotoxicity after switch to another chemotherapy
Fluoropyrimidine chemotherapy is widely used in many solid tumours, but is associated with cardiotoxicity. In…
Read More
January 21, 2023
January 2022: EMA approves dossier for new indication for drug in metastatic colorectal cancer
During most of 2021, Meducom worked hard to support a client and clinical experts in…
Read More
January 21, 2023
October 2021: Expert medical support for regulatory affairs and dossier writing
Regulatory approval and dossier creation require in-depth knowledge of the medical field involved, as well…
Read More
January 9, 2018
December 2017: Meducom supports advisory board
Shortly before the holidays, Meducom developed and organised a nephrology advisory board in Belgium for…
Read More